Ludovic Bigot

Characterization of a Large Panel of Patient-Derived Tumor Xenografts Representing the Clinical Heterogeneity of Human Colorectal Cancer

Sylvia Julien, Ana Merino‐Trigo, Ludovic Lacroix et al. · Clinical Cancer Research · 2012 · 365 citations · Full text

Medicine, Cancer Biology, Oncology +16

Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor Lorlatinib in ALK-Rearranged Lung Cancer

Gonzalo Recondo, Laura Mezquita, Francesco Facchinetti et al. · Clinical Cancer Research · 2019 · 167 citations · Full text

Medicine, Oncology, Pharmacology +16

Tumour spheres with inverted polarity drive the formation of peritoneal metastases in patients with hypermethylated colorectal carcinomas

Olivier Zajac, Joël Raingeaud, Fotine Libanje et al. · Nature Cell Biology · 2018 · 123 citations

Medicine, Cancer Biology, Oncology +14

Resistance to Selective FGFR Inhibitors in <i>FGFR-</i> Driven Urothelial Cancer

Francesco Facchinetti, Antoine Hollebecque, Floriane Brayé et al. · Cancer Discovery · 2023 · 76 citations · Full text

Medicine, Oncology, Pharmacology +14

NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations

Joshua C. Horan, Anupong Tangpeerachaikul, Aurélie Swalduz et al. · Cancer Discovery · 2024 · 45 citations · Full text

Medicine, Oncology, Pharmacology +13